LINDIE UNSEL: Open Payments
NPI 1417265836 · OWENSBORO, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,773 in 79 payments from 16 companies in 2025. Trend: 2023 $2,796 · 2024 $2,151 · 2025 $1,773
Food & beverage: $1,773
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $383 |
| Actelion Pharmaceuticals US, Inc. | 8 | $282 |
| GlaxoSmithKline, LLC. | 18 | $275 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $167 |
| Insmed, Inc. | 7 | $129 |
| Grifols USA, LLC | 4 | $88 |
| GENZYME CORPORATION | 4 | $69 |
| Amgen Inc. | 4 | $67 |
| Baxter Healthcare | 3 | $63 |
| Philips North America LLC | 3 | $53 |
Products named: FASENRA, UPTRAVI, TRELEGY ELLIPTA, Arikayce, NUCALA, DUPIXENT, TEZSPIRE, Prolastin-C Liquid.
Industry payments across KY — which companies pay providers there.
